Tuesday, September 22, 2009

Verichip Wins Patent License for Implanted H1N1 Detection Chip in Humans

This is a relative surprise for H1N1-related stock news: a high-tech company that trippled in price due to H1N1.

VeriChip Corp (CHIP) soared yesterday after the company was granted an exclusive license to two patents, which will help it to develop implantable virus detection systems in humans.

The patents are for biosensors that can detect the H1N1 and other viruses, and biological threats such as methicillin-resistant Staphylococcus aureus.

This is very interesting technology. The technology will combine with VeriChip’s implantable radio frequency identification devices to develop virus triage detection systems, which will provide multiple levels of identification:

1. Identify the agent as virus or non-virus.

2. Classify the virus and alert the user to the presence of pandemic threat viruses

3. Identify the precise pathogen (wow!)

CHIP went from a $1 stock to over $3 yesterday:

Stumble Upon Toolbar

No comments:

Financial TV

Blog Archive

// adding Google analytics